Literature DB >> 16183982

Health consequences of smoking 1-4 cigarettes per day.

K Bjartveit1, A Tverdal.   

Abstract

OBJECTIVES: To determine the risk in men and women smoking 1-4 cigarettes per day of dying from specified smoking related diseases and from any cause.
DESIGN: Prospective study.
SETTING: Oslo city and three counties in Norway. PARTICIPANTS: 23,521 men and 19,201 women, aged 35-49 years, screened for cardiovascular disease risk factors in the mid 1970s and followed throughout 2002. OUTCOMES: Absolute mortality and relative risks adjusted for confounding variables, of dying from ischaemic heart disease, all cancer, lung cancer, and from all causes.
RESULTS: Adjusted relative risk (95% confidence interval) in smokers of 1-4 cigarettes per day, with never smokers as reference, of dying from ischaemic heart disease was 2.74 (2.07 to 3.61) in men and 2.94 (1.75 to 4.95) in women. The corresponding figures for all cancer were 1.08 (0.78 to 1.49) and 1.14 (0.84 to 1.55), for lung cancer 2.79 (0.94 to 8.28) and 5.03 (1.81 to 13.98), and for any cause 1.57 (1.33 to 1.85) and 1.47 (1.19 to 1.82).
CONCLUSIONS: In both sexes, smoking 1-4 cigarettes per day was associated with a significantly higher risk of dying from ischaemic heart disease and from all causes, and from lung cancer in women. Smoking control policymakers and health educators should emphasise more strongly that light smokers also endanger their health.

Entities:  

Mesh:

Year:  2005        PMID: 16183982      PMCID: PMC1748107          DOI: 10.1136/tc.2005.011932

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  6 in total

1.  Coronary heart disease, cancer and mortality in male middle-aged light smokers.

Authors:  A Rosengren; L Wilhelmsen; H Wedel
Journal:  J Intern Med       Date:  1992-04       Impact factor: 8.989

2.  Importance of light smoking and inhalation habits on risk of myocardial infarction and all cause mortality. A 22 year follow up of 12 149 men and women in The Copenhagen City Heart Study.

Authors:  E Prescott; H Scharling; M Osler; P Schnohr
Journal:  J Epidemiol Community Health       Date:  2002-09       Impact factor: 3.710

3.  Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. A 12-year follow-up of the Finnmark Study.

Authors:  I Njølstad; E Arnesen; P G Lund-Larsen
Journal:  Circulation       Date:  1996-02-01       Impact factor: 29.690

4.  Preinfarction blood pressure and smoking are determinants for a fatal outcome of myocardial infarction: a prospective analysis from the Finnmark Study.

Authors:  I Njølstad; E Arnesen
Journal:  Arch Intern Med       Date:  1998-06-22

5.  Smoking cessation and time course of decreased risks of coronary heart disease in middle-aged women.

Authors:  I Kawachi; G A Colditz; M J Stampfer; W C Willett; J E Manson; B Rosner; F E Speizer; C H Hennekens
Journal:  Arch Intern Med       Date:  1994-01-24

6.  Mortality in relation to smoking history: 13 years' follow-up of 68,000 Norwegian men and women 35-49 years.

Authors:  A Tverdal; D Thelle; I Stensvold; P Leren; K Bjartveit
Journal:  J Clin Epidemiol       Date:  1993-05       Impact factor: 6.437

  6 in total
  137 in total

1.  HIV and general cardiovascular risk.

Authors:  Bernadette Capili; Joyce K Anastasi; Olugbenga Ogedegbe
Journal:  J Assoc Nurses AIDS Care       Date:  2011-02-01       Impact factor: 1.354

2.  Burden of smoking on cause-specific mortality: application to the Nurses' Health Study.

Authors:  Stacey A Kenfield; Esther K Wei; Bernard A Rosner; Robert J Glynn; Meir J Stampfer; Graham A Colditz
Journal:  Tob Control       Date:  2010-06       Impact factor: 7.552

3.  Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial.

Authors:  Alan R Lifson; Jacqueline Neuhaus; Jose Ramon Arribas; Mary van den Berg-Wolf; Ann M Labriola; Timothy R H Read
Journal:  Am J Public Health       Date:  2010-08-19       Impact factor: 9.308

4.  Level of cigarette consumption and quit behavior in a population of low-intensity smokers--longitudinal results from the International Tobacco Control (ITC) survey in Mexico.

Authors:  Kamala Swayampakala; James Thrasher; Matthew J Carpenter; Luz Myriam Reynales Shigematsu; Ana-Paula Cupertio; Carla J Berg
Journal:  Addict Behav       Date:  2012-12-16       Impact factor: 3.913

Review 5.  Smoking cessation: significance and implications for children.

Authors:  Andrea T Borchers; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

Review 6.  Symbiotic relationship of pharmacogenetics and drugs of abuse.

Authors:  Joni L Rutter
Journal:  AAPS J       Date:  2006-03-24       Impact factor: 4.009

7.  Smoking-cessation e-referrals: a national dental practice-based research network randomized controlled trial.

Authors:  Midge N Ray; Ellen Funkhouser; Jessica H Williams; Rajani S Sadasivam; Gregg H Gilbert; Heather L Coley; D Brad Rindal; Thomas K Houston
Journal:  Am J Prev Med       Date:  2014-02       Impact factor: 5.043

8.  Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; V N Maturu; Sahajal Dhooria; K T Prasad; Inderpaul S Sehgal; Lakshmikant B Yenge; Aditya Jindal; Navneet Singh; A G Ghoshal; G C Khilnani; J K Samaria; S N Gaur; D Behera
Journal:  Lung India       Date:  2013-07

9.  Characteristics of intermittent smokers and their association with quit intentions in a sample of heavy-drinking HIV-infected men who have sex with men.

Authors:  Patricia A Cioe; Kristi E Gamarel; David W Pantalone; Peter M Monti; Kenneth H Mayer; Christopher W Kahler
Journal:  AIDS Care       Date:  2016-10-02

10.  Dual Versus Never Use of E-Cigarettes Among American Indians Who Smoke.

Authors:  Dorothy A Rhoades; Ashley L Comiford; Justin D Dvorak; Kai Ding; Leslie M Driskill; Audrea M Hopkins; Paul Spicer; Theodore L Wagener; Mark P Doescher
Journal:  Am J Prev Med       Date:  2019-08-01       Impact factor: 5.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.